23andMe Holding Co.
NASDAQ:ME
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.5305
4.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of ME.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
CVS Health Corp
NYSE:CVS
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
|
| US |
|
Cigna Corp
NYSE:CI
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
23andMe Holding Co.
Balance Sheet Decomposition
23andMe Holding Co.
| Current Assets | 161.6m |
| Cash & Short-Term Investments | 79.4m |
| Receivables | 10.1m |
| Other Current Assets | 72.2m |
| Non-Current Assets | 115.8m |
| PP&E | 54.2m |
| Intangibles | 48m |
| Other Non-Current Assets | 13.6m |
| Current Liabilities | 145.8m |
| Accounts Payable | 7.8m |
| Accrued Liabilities | 65.3m |
| Other Current Liabilities | 72.7m |
| Non-Current Liabilities | 61.4m |
| Other Non-Current Liabilities | 61.4m |
Free Cash Flow Analysis
23andMe Holding Co.
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
23andMe Holding Co.
|
Revenue
|
208.8m
USD
|
|
Cost of Revenue
|
-99m
USD
|
|
Gross Profit
|
109.8m
USD
|
|
Operating Expenses
|
-317.3m
USD
|
|
Operating Income
|
-207.5m
USD
|
|
Other Expenses
|
-175.3m
USD
|
|
Net Income
|
-382.9m
USD
|
ME Profitability Score
Profitability Due Diligence
23andMe Holding Co.'s profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
23andMe Holding Co.'s profitability score is hidden . The higher the profitability score, the more profitable the company is.
ME Solvency Score
Solvency Due Diligence
23andMe Holding Co.'s solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
23andMe Holding Co.'s solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ME Price Targets Summary
23andMe Holding Co.
According to Wall Street analysts, the average 1-year price target for
ME
is 2.1216 USD
with a low forecast of 2.1008 USD and a high forecast of 2.184 USD.
Dividends
Current shareholder yield for
ME is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?